| |
All patients (n = 102)
|
Severe group (n = 33)
|
Critical group (n = 69)
|
P-value
|
|---|
|
Characteristics
|
|
Age, years
|
66.2 (30 ~ 93)
|
64.9 (30 ~ 82)
|
66.1 (36 ~ 93)
|
0.686
|
|
Sex
|
0.178
|
|
Men
|
68 (66.7%)
|
19 (57.6%)
|
49 (71.0%)
| |
|
Women
|
34 (33.3%)
|
14 (42.4%)
|
20 (29.0%)
|
|
Bacterial etiology
|
|
A. baumanniia
|
50 (49.0%)
|
10 (30.3%)
|
40 (58.0%)
|
0.009
|
|
CRABa
|
47 (46.1%)
|
9 (27.3%)
|
38 (55.1%)
|
0.008
|
|
K. pneumoniaea
|
35 (34.3%)
|
6 (18.2%)
|
29 (42.0%)
|
0.018
|
|
CRKPa
|
32 (31.4%)
|
5 (15.2%)
|
27 (39.1%)
|
0.015
|
|
Treatment before SBIs
|
|
Antiviral therapy
|
96 (94.1%)
|
29 (87.9%)
|
67 (97.1%)
|
0.084
|
|
Antibiotic therapy
|
99 (97.1%)
|
31 (93.9%)
|
68 (98.6%)
|
0.244
|
|
Outcomes
|
< 0.0001
|
|
Discharge
|
52 (51.0%)
|
28 (84.8%)
|
24 (34.8%)
| |
|
Death
|
50 (49.0%)
|
5 (15.2%)
|
45 (65.2%)
|
- Data are median (IQR) or n (%). P values comparing severe group and critical group are from Mann-Whitney U test, χ2 test, or Fisher’s exact test
- aNumber of patients suffering from a certain bacterial infection
